Concepedia
Statistics
Publications
1
Citations
119
H-Index
Active since
2011
J. Park is an author specializing in tyrosine kinase inhibitors, tumor invasion assessment, and cancer pharmacology.
Publications per year
2011–2011
Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC).
Ann‐Lii Cheng, Yubin Kang, J. Park et al. · Journal of Clinical Oncology · 2011 · 119 citations
Medicine, Oncology, Pharmacology +16
1–1 of 1